National Research (NASDAQ:NRC) Trading Up 6.9%

National Research Co. (NASDAQ:NRC - Get Free Report)'s share price shot up 6.9% on Friday . The company traded as high as $31.58 and last traded at $30.73. Approximately 74,671 shares traded hands during trading, an increase of 7% from the average daily volume of 70,051 shares. The stock had previously closed at $28.75.

Analyst Ratings Changes

Separately, TheStreet cut National Research from a "b-" rating to a "c+" rating in a report on Thursday, January 11th.

National Research Price Performance

The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.60. The firm has a market cap of $740.78 million, a P/E ratio of 24.85 and a beta of 0.45. The business has a fifty day moving average of $36.90 and a 200 day moving average of $39.13.

National Research (NASDAQ:NRC - Get Free Report) last released its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%. The company had revenue of $38.00 million during the quarter.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Friday, June 28th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.48 annualized dividend and a yield of 1.55%. National Research's payout ratio is 38.40%.

Institutional Investors Weigh In On National Research

A number of institutional investors and hedge funds have recently made changes to their positions in NRC. Vanguard Group Inc. boosted its holdings in National Research by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 980,693 shares of the company's stock worth $43,513,000 after buying an additional 10,454 shares during the period. Conestoga Capital Advisors LLC grew its holdings in shares of National Research by 0.5% during the 1st quarter. Conestoga Capital Advisors LLC now owns 784,656 shares of the company's stock valued at $31,080,000 after purchasing an additional 3,850 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of National Research by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company's stock valued at $25,176,000 after purchasing an additional 7,531 shares during the last quarter. iA Global Asset Management Inc. bought a new stake in National Research in the 3rd quarter worth $11,124,000. Finally, Comerica Bank bought a new stake in National Research in the 3rd quarter worth $6,939,000. Institutional investors and hedge funds own 47.26% of the company's stock.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.